Abstract

Abstract Anti-CRIT-ed1 (recognising the first extracellular domain of CRIT) was passively transferred into mice which were subsequently challenged with 500 trypomastigotes of T. brucei subsp. brucei. At a peak of infection, eight days after challenge infection, mice that had received 0.5 mg anti-CRIT-ed1 (ascites) had significantly reduced levels of parasitaemia compared to control mice. This inhibiton was also found to be dose-dependent. As passive transfer of anti-CRIT-ed2, the antibody recognising the second extracellular domain did not reduce parasitaemia, the protection was deemed specific. The protection afforded by passive transfer of anti-CRIT-ed1 also delayed mortality. To exclude the possibility that the reduction in parasitaemia was due to intact IgG inducing complement-mediated lysis of trypomastigotes we found that whereas anti-CRIT-ed1 was unable to induce complement-mediated lysis of cultured trypomastigotes, the sera from T. brucei subsp brucei-infected mice induced lysis.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.